Target intelligence / Profile preview

DAZ-associated protein 2 (DAZAP2)

Target
DAZAP2
Molecular classification
Adaptor protein, Proline-rich protein, Other
01

Overview

DAZ-associated protein 2 (DAZAP2) is a small (~17 kDa) proline-rich adaptor protein encoded by the DAZAP2 gene on chromosome 12, structurally characterized by a central proline-rich region and SH2/SH3 binding sites[3]. The protein is expressed ubiquitously, with notable function in the cytoplasm and nucleus. DAZAP2 interacts with deleted in azoospermia (DAZ), SARA (Smad anchor for receptor activation), eukaryotic initiation factor 4G, and the E3 ubiquitin ligase SIAH1. It regulates the stability of key signaling proteins (notably the kinase HIPK2), modulates the p53 pathway response to DNA damage, affects stress granule formation, RNA splicing, and is implicated in spermatogenesis[1][2][3][5]. Downregulation of DAZAP2 has been linked to multiple myeloma, and recent research indicates it acts as a pan-coronavirus restriction factor inhibiting viral RNA replication[4]. DAZAP2 is not classified as a classical drug target (such as a receptor or enzyme), but rather as an adaptor protein in key cellular pathways.

Other names
DAZAP2KIAA0058PRTBDeleted in azoospermia-associated protein 2Proline-rich transcript in brain proteinProline-rich transcript in brainBrain-expressed protein
02

Mechanism of action

No drugs act on DAZAP2 directly; any mechanisms would be indirect via pathways it regulates.

03

Biological functions

Signal transductionGene/transcription regulationSpermatogenesisStress granule formationRNA splicingCell proliferation and differentiation
04

Disease associations

AzoospermiaMultiple myelomaCancer chemosensitivityOther
05

Biomarkers

Possible biomarker: Downregulation in multiple myeloma has been reported, suggesting utility in disease monitoring, but this is not clinically validated.

Beyond the preview

Go deeper on DAZ-associated protein 2 (DAZAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DAZ-associated protein 2 (DAZAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call